EPISODIC MIGRAINE

This study tests whether a medicine called eptinezumab can prevent migraines in children and teens aged 6 to 17 who have episodic migraine. Participants receive the drug or a placebo by IV every 12 weeks. The main goal is to see if it reduces the number of migraine days per month…

This study tests whether atorvastatin, a drug usually used for cholesterol, can prevent migraine attacks in people with episodic migraine. Researchers will compare two daily doses (20 mg and 40 mg) to a placebo in 450 adults aged 18-65. The goal is to see if the drug reduces the …

This study tests whether atogepant, a drug already approved for adults, can safely prevent migraines in children aged 6 to 17. About 450 participants will take a daily tablet (low-dose, high-dose, or placebo) for 12 weeks. The goal is to reduce the number of migraine days each mo…

This study tests whether Xeomin injections (a botulinum toxin type A) can prevent episodic migraines in adults. About 990 participants will receive either Xeomin or a placebo injected into head and neck muscles every 12 weeks for about a year. The main goal is to see if Xeomin re…

This study tests an injection called IPN10200 to prevent migraines in adults with episodic or chronic migraine. The drug works by blocking pain-causing chemicals in the brain. About 641 participants will receive either the drug or a placebo to find the safest and most effective d…

This study is checking the safety and effectiveness of atogepant, a drug already approved for migraine prevention, in Korean adults. About 3000 people with chronic or episodic migraines will take the drug as prescribed by their doctor and be followed for up to 12 weeks. The goal …

This study tests whether injecting a numbing medication and a steroid into the scalp nerves can stop an active migraine and prevent future ones. Researchers will enroll 60 people who have episodic migraines (4 to 14 days per month). The goal is to see if this nerve block can elim…

This study follows 700 people with migraine who are taking newer preventive drugs (anti-CGRP medications) to see how well they work in everyday life. Researchers will track changes in monthly headache days and migraine impact over two years. The goal is to understand real-world b…

This study tests whether Gou-Teng-San (GTS), a traditional herbal medicine, can help adults with episodic migraine. About 40 participants will be randomly assigned to receive GTS or a placebo. Researchers will measure if GTS reduces the number of migraine days and eases symptoms …